Neurogene Inc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurogene Inc and other ETFs, options, and stocks.About NGNE
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
CEORachel L. McMinn
CEORachel L. McMinn
Employees107
Employees107
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2007
Founded2007
Employees107
Employees107
NGNE Key Statistics
Market cap298.80M
Market cap298.80M
Price-Earnings ratio-4.35
Price-Earnings ratio-4.35
Dividend yield—
Dividend yield—
Average volume184.08K
Average volume184.08K
High today—
High today—
Low today—
Low today—
Open price$19.54
Open price$19.54
Volume0.00
Volume0.00
52 Week high$37.27
52 Week high$37.27
52 Week low$6.88
52 Week low$6.88
Stock Snapshot
The current Neurogene Inc(NGNE) stock price is $19.28, with a market capitalization of 298.8M. The stock trades at a price-to-earnings (P/E) ratio of -4.35.
On 2025-12-19, Neurogene Inc(NGNE) shares started trading at $19.54, with intraday highs of — and lows of —.
Trading volume for Neurogene Inc(NGNE) stock has reached 0, versus its average volume of 184.08K.
The stock's 52-week range extends from a low of $6.88 to a high of $37.27.
The stock's 52-week range extends from a low of $6.88 to a high of $37.27.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NGNE. This list is generated using Robinhood data, and it’s not a recommendation.